Cholangiocarcinoma Presenting as Humoral Hypercalcemia of Malignancy: A Case Report and Literature Review
Open Access
- 27 December 2019
- journal article
- review article
- Published by Springer Nature in Cureus
- Vol. 11 (12) , e6481
Abstract
Humoral hypercalcemia of malignancy (HHM) is most commonly encountered in squamous cell carcinoma (SCC) of different organs, and It is characterized by elevated parathyroid hormone-related peptide (PTHrP) levels. It may be seen as a manifestation of cholangiocarcinoma (CCC) at presentation and later in the course of the disease. However, HHM due to intrahepatic cholangiocarcinoma is a rare association and is associated with a poor prognosis. We herein report a case of hypercalcemia presenting as the first manifestation of an underlying rare variant of intrahepatic cholangiocarcinoma. Our patient is a 57-year-old male who presented to the emergency room with severe symptoms of constipation and polyuria and was admitted to the hospital for symptomatic hypercalcemia. He was found to have a hypermetabolic 15 cm liver mass, abdominal lymph nodes on imaging, which was subsequently diagnosed as adenosquamous cholangiocarcinoma by liver biopsy. This necessitated an urgent inpatient treatment with gemcitabine/cisplatin combination chemotherapy to control the aggressive nature of the malignancy. However, he deteriorated and expired after three months of his diagnosis. Adenosquamous cholangiocarcinoma is a very rare variant of a liver tumor. It develops due to squamous metaplasia of an underlying cholangiocarcinoma and usually has aggressive clinicopathological features. HMM is a life-threatening, yet unrecognized, phenomenon of cholangiocarcinoma, which represents a poor prognostic marker. Prompt recognition of this complication is important for preventing serious complications associated with hypercalcemia and to improve the quality of life of these patients.Keywords
This publication has 19 references indexed in Scilit:
- Quality and Outcomes of Treatment of Hypercalcemia of MalignancyCancer Investigation, 2015
- PTHrp comes full circle in cancer biologyBoneKEy Reports, 2015
- Adenosquamous carcinoma of the liverClinical and Molecular Hepatology, 2012
- Cholangiocarcinoma Producing Parathyroid Hormone-related Peptide Treated with Chemoradiation Using Gemcitabine and S-1Internal Medicine, 2009
- A Clinicopathologic Study of Primary Adenosquamous Carcinoma of the LiverJournal of Clinical Gastroenterology, 2005
- Hypercalcemia Associated with CancerNew England Journal of Medicine, 2005
- Liver fluke-associated cholangiocarcinomaBritish Journal of Surgery, 2002
- Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene.Genes & Development, 1994
- Evidence for a novel parathyroid hormone-related protein in fetal lamb parathyroid glands and sheep placenta: comparisons with a similar protein implicated in humoral hypercalcaemia of malignancyJournal of Endocrinology, 1988
- Mucoepidermoid Carcinoma of the LiverAmerican Journal of Clinical Pathology, 1971